Published in J Invest Dermatol on November 07, 2013
Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood (2015) 0.99
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget (2014) 0.92
Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer. RNA (2014) 0.92
MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma. J Invest Dermatol (2014) 0.87
STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells. Neoplasia (2015) 0.87
Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies. Cancer Res (2015) 0.86
Histone deacetylase inhibition reveals a tumor-suppressive function of MYC-regulated miRNA in breast and lung carcinoma. Cell Death Differ (2016) 0.85
TOX acts an oncological role in mycosis fungoides. PLoS One (2015) 0.83
MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. J Clin Invest (2015) 0.81
The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis. Viruses (2015) 0.80
Anti-Warburg effect of rosmarinic acid via miR-155 in gastric cancer cells. Drug Des Devel Ther (2015) 0.80
miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma. J Bone Oncol (2016) 0.79
Deep Sequencing Analysis of miRNA Expression in Breast Muscle of Fast-Growing and Slow-Growing Broilers. Int J Mol Sci (2015) 0.79
TOX gene: a novel target for human cancer gene therapy. Am J Cancer Res (2015) 0.76
BCL-W has a fundamental role in B cell survival and lymphomagenesis. J Clin Invest (2017) 0.75
Sensitivity of non-small cell lung cancer to erlotinib is regulated by the Notch/miR-223/FBXW7 pathway. Biosci Rep (2017) 0.75
miR‑223‑3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors. Int J Oncol (2016) 0.75
Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma. Dis Markers (2016) 0.75
Early changes in miRNA expression are predictive of response to extracorporeal photopheresis in cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol (2014) 0.75
miR-31 and miR-17-5p levels change during transformation of follicular lymphoma. Hum Pathol (2015) 0.75
TOX expression and role in CTCL. J Eur Acad Dermatol Venereol (2016) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
Identification of novel genes coding for small expressed RNAs. Science (2001) 44.44
An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science (2001) 44.16
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature (2000) 39.31
An extensive class of small RNAs in Caenorhabditis elegans. Science (2001) 34.17
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA. Science (2002) 18.37
A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell (2005) 9.22
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature (2008) 8.69
miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA (2008) 5.48
Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics (2007) 4.91
Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer (2009) 4.66
An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell (2007) 3.34
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood (2011) 2.96
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell (2011) 2.89
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell (2007) 2.55
Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood (2009) 2.26
Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context. Curr Mol Med (2006) 2.01
A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet (2011) 1.99
MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood (2010) 1.88
Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. EMBO J (2003) 1.85
Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol (1996) 1.81
Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA (1988) 1.75
Acquisition of a functional T cell receptor during T lymphocyte development is enforced by HEB and E2A transcription factors. Immunity (2007) 1.68
Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells. Oncogene (2007) 1.35
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25
The many roles of TOX in the immune system. Curr Opin Immunol (2011) 1.10
Molecular markers of early-stage mycosis fungoides. J Invest Dermatol (2012) 1.04
miRNA expression profiling of mycosis fungoides. Mol Oncol (2011) 1.01
The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas. Cancer (2008) 0.94
Deep-sequencing analysis reveals that the miR-199a2/214 cluster within DNM3os represents the vast majority of aberrantly expressed microRNAs in Sézary syndrome. J Invest Dermatol (2012) 0.85